Marcus Sucksdorff
Turku, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Correction: Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis.
Journal: Journal of neuroinflammation
Published: February 03, 2026
Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis.
Journal: Journal of neuroinflammation
Published: April 11, 2025
Predictors of risk of secondary progression in multiple sclerosis.
Journal: Therapeutic advances in neurological disorders
Published: March 08, 2025
Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis.
Journal: BMJ neurology open
Published: January 06, 2025
P2X 7-receptor binding in new-onset and secondary progressive MS - a [11C]SMW139 PET study.
Journal: EJNMMI research
Published: June 13, 2024
Sex Comparison of White-Blood-Cell Responses to Acute Vigorous-Intensity Aerobic Exercise.
Journal: International journal of sports physiology and performance
Published: April 05, 2024
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: November 10, 2023
Association of serum neurofilament light with microglial activation in multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: January 04, 2023
Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: December 11, 2022
PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report.
Journal: Journal of neurology
Published: November 30, 2022
Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis.
Journal: European journal of neurology
Published: October 14, 2022
TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 09, 2022
Last Updated: 09/26/2026